Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shareholder Meeting - Don't expect anything new

Shareholder Meeting - Don't expect anything new

posted on Oct 02, 2007 07:25AM

No matter how many questions are asked, how tricky they may appear or what the expectations for information slippage may be, the board are fully aware, and guided by, Regulation FD

 

http://www.sec.gov/rules/final/33-7881.htm

 

SUMMARY: The Securities and Exchange Commission is adopting new rules to address three issues: the selective disclosure by issuers of material nonpublic information; when insider trading liability arises in connection with a trader's "use" or "knowing possession" of material nonpublic information; and when the breach of a family or other non-business relationship may give rise to liability under the misappropriation theory of insider trading. The rules are designed to promote the full and fair disclosure of information by issuers, and to clarify and enhance existing prohibitions against insider trading.

 

If it isn't public by the Shareholder Meeting, it will not be disclosed there.

 

 

 

 

Be well

Share
New Message
Please login to post a reply